On Friday, the Food and Drug Administration (FDA) held its first public hearing on regulating cannabis. The hearing was intended “to obtain scientific data and information about the safety, manufacturing, product quality, marketing, labeling and sale of products containing cannabis or cannabis-derived compounds.”
A wide variety of industry reps presented their cases to the FDA, including professionals in healthcare, agriculture, manufacturing, public safety and retail. Patients and government officials also had a say.
One speaker was Andy Snyder, founder of Manward Press. Andy is a good friend of ours. We have a lot of respect for him and all the work he’s done to build his company. And we share an interest in cannabis.
So we were thrilled to hear that Andy was taking his pro-cannabis case to the FDA. Here’s an excerpt from his testimony:
While the evidence supporting both the safety and efficacy of CBD continues to pile up, response at the federal level has been slow at best and nonexistent at worst… We’re talking about a safe, natural compound with seemingly endless benefits for users. One with very little, if any risk of significant downside. For my money, CBD may be one of God’s greatest gifts to mankind and the pursuit of health. It’s outrageous that corporate greed and red tape have forced most Americans to spend the last eight decades in the dark.
A number of other speakers echoed Andy’s sentiments. Others argued that marijuana is dangerous and addictive.
At the end of the day, it’s a good sign that the FDA is opening up the cannabis conversation. The government moves slowly, but sometimes change has to happen one step at a time.
On to the News Fix…
Illinois Senate approves marijuana legalization: The Illinois Senate voted on Wednesday to approve a bill legalizing marijuana, just two days before the legislative session ended (Marijuana Moment).
The bill will allow adults 21 and older to consume, possess and purchase certain amounts of cannabis for personal use. It also aims to create a legally regulated system of marijuana production and sales. The bill also contains several provisions aimed at promoting social equity in the legal industry, including expunging the records of people with convictions for marijuana possession of 30 grams or less.
It sounds like progress!
Study reports link between medical cannabis legalization and opioid prescription rate decline: Yet another study has emerged linking medical cannabis legalization and opioid prescription rates. (We reported on a similar study last week.) Researchers at the University of Texas discovered “a significant interaction between age and cannabis law on opioid prescriptions” (High Times).
For the oldest age group, 56 to 64, researchers found no significant interactions between age, marijuana law and opioid prescriptions. But patients in the 18 to 55 age range received significantly fewer and shorter opioid prescriptions in states with legal medical marijuana.
Pico raises $4.5 million from Stripe and Precursor Ventures: Stripe and Precursor Ventures are leading a $4.5 million seed round raise for software startup Pico (TechCrunch). Pico has built an audience relationship management platform that lets businesses build on customer relationships.
Stripe’s investment shows an expanding interest in the publishing industry. The company publishes an engineering magazine and has formed Stripe Press, which produces books on startups and engineering.
Mental health startups are raising millions: Talkspace, a mental health startup, just raised a $50 million funding round led by Revolution Growth (PitchBook). Talkspace connects customers to licensed therapists through audio, text and video messages.
Talkspace is one of many mental health-focused startups that have been emerging over the years. Calm, a meditation startup, raised $88 million in February at a $1 billion valuation. And it was named Apple’s iPhone App of the Year in 2017.
Australia releases crypto guidelines: The Australian Securities and Investment Commission released new initial coin offering (ICO) and cryptocurrency guidelines on Thursday (Cointelegraph).
The regulator specified that if a crypto asset is a financial product, then the issuer and the firms dealing with it are required to hold an Australian financial services license. The report also notes that miners will be considered part of the clearing and settlement process in some cases.
Kik launches crowdfunding campaign for SEC fight: Kik, a Canada-based messaging app, has launched a crowdfunding campaign to fund a court battle with the Securities and Exchange Commission (SEC) over its 2017 ICO (CoinDesk). The battle comes after the SEC said Kik’s kin token might be a security, not a currency as Kik claims.
But its fight is bigger than that. Kik’s “Defend Crypto” website explains that the case will impact the entire industry, setting a precedent for cryptocurrency regulation in the U.S. And it could serve as a new Howey Test (a test to determine whether certain transactions qualify as investment contracts).
Kik has raised more than $5 million so far and is accepting donations in the form of 19 different cryptocurrencies.
Another copyright claim for bitcoin white paper appears: We’ve all heard about Craig Wright, who has claimed to be the creator of bitcoin and who has faced his share of skeptics. But another contender has entered the legal fight over Satoshi Nakamoto’s white paper. A copyright registration for the bitcoin white paper was filed on May 24. The registration lists Wei Liu as the author of the pseudonymous paper (CoinDesk).
It’s not clear who Wei Liu is or why the registration was filed. But one thing is clear to the Fix. Wright has made legal threats against those who dispute his claim to the Satoshi name. And he still hasn’t been able to provide indisputable proof for his case. So if Wei Liu (or someone else) wants to throw in a counterpunch, it could be illuminating at best… and entertaining at worst.
Have a great weekend!
Assistant Managing Editor, Early Investing
The post News Fix: The FDA Opens Up the Cannabis Conversation appeared first on Early Investing.
Source: Early Investing